Ehong Gu
Director Financiero/CFO en LIANBIO .
Fortuna: 19 343 $ al 31/05/2024
Perfil
Ehong Gu is currently the Chief Financial & Accounting Officer at LianBio.
Previously, she worked as the Assistant Vice President-Finance at CStone Pharmaceuticals Co. Ltd.
from 2019 to 2021.
She holds an MBA from Rotman School of Management and an undergraduate degree from Shanghai University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LIANBIO SPONSORED ADR
0.05% | 09/04/2024 | 58 873 ( 0.05% ) | 19 343 $ | 31/05/2024 |
LIANBIO
-.--% | 19/12/2023 | 0 ( -.--% ) | - $ | 31/05/2024 |
Cargos activos de Ehong Gu
| Empresas | Cargo | Inicio |
|---|---|---|
| LIANBIO | Director Financiero/CFO | 19/12/2023 |
Antiguos cargos conocidos de Ehong Gu.
| Empresas | Cargo | Fin |
|---|---|---|
| CSTONE PHARMACEUTICALS | Corporate Officer/Principal | 01/01/2021 |
Formación de Ehong Gu.
| Rotman School of Management | Masters Business Admin |
| Shanghai University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| LIANBIO | Health Technology |
| CSTONE PHARMACEUTICALS | Health Technology |
- Bolsa de valores
- Insiders
- Ehong Gu
